Earnings release
Page 1
ALBEMARLEⓇ Albemarle Reports Third Quarter Sales Growth of 11 % and Increases Guidance Third Quarter 2021 Highlights ( Unless otherwise stated , all percent changes are based on year - over - year comparisons ) ● Contact : David Burke CHARLOTTE , N.C. - Nov. 3 , 2021 - Albemarle Corporation ( NYSE : ALB ) today announced its results for the third quarter ended September 30 , 2021 . Net sales of $ 830.6 million , an increase of 11 % ; Net sales increased 19 % excluding FCS Net loss of ( $ 392.8 ) million , or ( $ 3.36 ) per diluted share Exhibit 99.1 980.299.5533 Adjusted diluted EPS of $ 1.05 , a decrease of 4 % , excludes a $ 4.29 per share charge for a recent arbitration decision Adjusted EBITDA of $ 217.6 million , an increase of 1 % ; Adjusted EBITDA increased 14 % excluding FCS Increased FY 2021 guidance based on strong third quarter performance Announced agreement to acquire Guangxi Tianyuan New Energy Materials ( Tianyuan ) , which includes a lithium conversion plant ( Qinzhou ) designed to produce 25,000 mtpa with the potential to expand to 50,000 mtpa Announced agreements for strategic investments in China with plans to build two lithium hydroxide conversion plants , each initially targeting 50,000 mtpa MARBL Lithium Joint Venture ( MARBL ) to restart operations at the Wodgina Lithium Mine in Australia Advanced deployment of Albemarle Way of Excellence ( AWE ) operating model and submitted sustainability disclosure report to CDP ( formerly the Carbon Disclosure Project ) 1 " Despite supply chain challenges and increased raw material costs last quarter , we continued to deliver solid revenue and adjusted EBITDA growth , " said Albemarle CEO Kent Masters . " In October , we achieved first lithium carbonate production at our new La Negra III / IV conversion facility . We are making investments to add significant conversion capacity in China , initially targeting up to 150,000 metric tons of lithium hydroxide per year which will provide high - return growth opportunities aligned with the increasing demand from our customers . " Outlook Albemarle's improved outlook for the full - year 2021 reflects a strong third quarter performance and assumes continued global economic recovery as well as a modest improvement in operating performance compared to the full - year 2020. Full - year 2021 net sales guidance was revised higher which reflects higher volumes in its Lithium business and stronger pricing in its Bromine businesses . Adjusted EBITDA guidance improved due to higher net sales , as well as lower corporate costs and higher - than - expected Catalysts joint venture income . Capital expenditures were revised higher due to accelerated investments in growth , tight labor markets , and COVID related travel restrictions in Western Australia .